Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-17-005744
Filing Date
2017-11-20
Accepted
2017-11-20 17:26:27
Documents
51
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q imle_10q.htm 10-Q 449145
2 CERTIFICATION imle_ex311.htm EX-31.1 7510
3 CERTIFICATION imle_ex312.htm EX-31.2 7577
4 CERTIFICATION imle_ex321.htm EX-32.1 3414
5 CERTIFICATION imle_ex322.htm EX-32.2 3490
  Complete submission text file 0001477932-17-005744.txt   4576794

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imle-20170930.xml EX-101.INS 1288088
7 XBRL TAXONOMY EXTENSION SCHEMA imle-20170930.xsd EX-101.SCH 61909
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imle-20170930_cal.xml EX-101.CAL 35866
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imle-20170930_def.xml EX-101.DEF 184393
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE imle-20170930_lab.xml EX-101.LAB 293481
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imle-20170930_pre.xml EX-101.PRE 241703
Mailing Address 400 N. TUSTIN AVE. SUITE 225 SANTA ANA CA 92705
Business Address 400 N. TUSTIN AVE. SUITE 225 SANTA ANA CA 92705 714-667-7139
TransBiotec, Inc. (Filer) CIK: 0001425627 (see all company filings)

EIN.: 260731818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53316 | Film No.: 171214798
SIC: 2721 Periodicals: Publishing or Publishing & Printing